{
    "clinical_study": {
        "@rank": "114426", 
        "arm_group": [
            {
                "arm_group_label": "Scalp block with 0.5% plain marcaine", 
                "arm_group_type": "Experimental", 
                "description": "Anterior scalp block with 0.5% plain Marcaine 20 ml."
            }, 
            {
                "arm_group_label": "Scalp block with 0.9% normal saline", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Anterior scalp block with 0.9% normal saline 20 ml."
            }
        ], 
        "brief_summary": {
            "textblock": "Anterior scalp block with 0.5% plain Marcaine 20 ml. may reduce the intraoperative opioid\n      consumption in neurosurgical patients who undergoing the supratentorial craniotomy compared\n      to those who receive 0.9% normal saline solution (placebo)."
        }, 
        "brief_title": "Scalp Nerve Block and Opioid Consumption in Brain Surgery", 
        "completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Brain Tumour", 
        "condition_browse": {
            "mesh_term": "Brain Neoplasms"
        }, 
        "detailed_description": {
            "textblock": "Anterior scalp block with 0.5% plain Marcaine 20 ml. may reduce the intraoperative opioid\n      consumption in neurosurgical patients who undergoing the supratentorial craniotomy compared\n      to those who receive 0.9% normal saline solution (placebo).\n\n      A Prospective Randomized Double Blind Control"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Patients who have supratentorial brain tumor\n\n          2. Patients have been scheduled to undergo an elective craniotomy to remove tumor in any\n             surgical position\n\n          3. Patients have been general anesthetized with endotracheal intubation and control\n             ventilation\n\n          4. Patients who have provided consent for the participation in the research and for the\n             use of their medical record in research\n\n        Exclusion Criteria:\n\n          1. Pregnant patients\n\n          2. Patients who have a history of local anesthetic allergy and/ or anaphylaxis"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "95", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 26, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02057367", 
            "org_study_id": "ANE2556-01510"
        }, 
        "intervention": [
            {
                "arm_group_label": "Scalp block with 0.5% plain marcaine", 
                "description": "Anterior scalp block will be done by using 0.5% plain Marcaine 20 ml.", 
                "intervention_name": "Scalp block with 0.5% plain Marcaine", 
                "intervention_type": "Drug", 
                "other_name": "Code 1"
            }, 
            {
                "arm_group_label": "Scalp block with 0.9% normal saline", 
                "description": "Anterior scalp block will be done by using 0.9% normal saline 20 ml.", 
                "intervention_name": "Scalp block with 0.9% normal saline", 
                "intervention_type": "Drug", 
                "other_name": "Code 2"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Bupivacaine", 
                "Analgesics, Opioid"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "supratentorial brain tumour", 
            "craniotomy"
        ], 
        "lastchanged_date": "February 7, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Chiang Mai", 
                    "country": "Thailand", 
                    "zip": "50200"
                }, 
                "name": "Chiang Mai University"
            }
        }, 
        "location_countries": {
            "country": "Thailand"
        }, 
        "number_of_arms": "2", 
        "official_title": "The Effect of Pre-incisional Anterior Scalp Block on Intraoperative Opioid Consumption in Adult Patients Undergoing Elective Craniotomy to Remove Tumor: A Prospective Randomized Controlled", 
        "other_outcome": {
            "description": "The rate of immediate extubation before transferring to the intensive care unit (ICU) compared between patients who received 0.5% plain Marcaine and 0.9% normal saline solution.", 
            "measure": "extubation", 
            "safety_issue": "No", 
            "time_frame": "end of surgery, before transferring to the intensive care unit"
        }, 
        "overall_official": {
            "affiliation": "Chiang Mai University", 
            "last_name": "Pathomporn Pin-on, M.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Enrolling by invitation", 
        "oversight_info": {
            "authority": "Thailand: Ethical Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "December 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "The overall intravenous fentanyl consumption (microgram/ kilogram) during the surgery. The decision to administer fentanyl is guided by the changes of blood pressure and/ or heart rate greater than 20% from baseline level.", 
            "measure": "Intraoperative opioid consumption", 
            "safety_issue": "No", 
            "time_frame": "During the supratentorial craniotomy surgery"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02057367"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Chiang Mai University", 
            "investigator_full_name": "Pathomporn Pin on, M.D.", 
            "investigator_title": "Department of Anesthesiology", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "The maximal systolic blood pressure within the first 5 minutes after skull pin insertion will be recorded.\nThe systolic blood pressure change from baseline will be calculated. The unit is mmHg.", 
                "measure": "systolic blood pressure change", 
                "safety_issue": "No", 
                "time_frame": "within 5 minutes after skull pin insertion"
            }, 
            {
                "description": "The maximal heart rate within the first 5 minutes after skull pin insertion will be recorded.\nThe heart rate change from baseline level will be calculated. The unit is beats per minute.", 
                "measure": "Heart rate change", 
                "safety_issue": "No", 
                "time_frame": "within 5 minutes after skull pin insertion"
            }
        ], 
        "source": "Chiang Mai University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Chiang Mai University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}